Key result
Among 25,686 US outpatients with atherothrombosis or risk factors, only 65% with known disease received ≥3 of 4 major secondary prevention drug classes, varying by region and physician specialty.
Population
25,686 outpatients in the United States aged ≥45 years with either established atherothrombotic disease or…
Design
Cross-sectional
Authors
Loading...
Suboptimal secondary prevention adherence persists in US outpatients; leaves open how regional and specialty factors drive implementation gaps.
Observational (n=25,686)
Yes
Adherence to guideline-recommended preventive therapies in US outpatients varies significantly by geographic region and treating physician specialty, highlighting gaps in the implementation of evidence-based care.
Kumar et al. (2009) conducted an observational in Atherothrombosis or risk factors (n=25,686). Geographic region and physician specialty was evaluated on Use of guideline-recommended preventive therapies. Among 25,686 US outpatients with atherothrombosis or risk factors, only 65% with known disease received ≥3 of 4 major secondary prevention drug classes, varying by region and physician specialty.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: